Dikoma C Shungu Selected Research

Dikoma C Shungu Research Topics

Disease

10	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 05/2009
8	Schizophrenia (Dementia Praecox) 01/2021 - 05/2012
8	Anxiety Disorders (Anxiety Disorder) 04/2013 - 06/2004
5	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2017 - 04/2009
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 12/2008
4	Neoplasms (Cancer) 03/2007 - 10/2003
3	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 09/2015
3	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 08/2015 - 11/2012
2	MELAS Syndrome (Syndrome, MELAS) 01/2022 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021 - 01/2009
2	Fibromyalgia (Fibrositis) 01/2017 - 11/2015
2	Nervous System Diseases (Neurological Disorders) 01/2016 - 01/2007
2	Treatment-Resistant Depressive Disorder 08/2015 - 05/2009
2	Parkinson Disease (Parkinson's Disease) 01/2015 - 05/2014
2	Anhedonia 05/2014 - 02/2012
2	Overweight 01/2014 - 06/2008
2	Cognitive Dysfunction 01/2014 - 04/2005
2	Insulin Resistance 01/2011 - 04/2009
2	Essential Tremor (Essential Tremors) 08/2007 - 11/2002
2	Glioma (Gliomas) 03/2007 - 01/2006
2	Wounds and Injuries (Trauma) 06/2006 - 10/2003
1	Alzheimer Disease (Alzheimer's Disease) 12/2021
1	Disease Progression 12/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2018
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2017
1	Apnea 01/2017
1	Tics (Tic) 12/2016
1	Tourette Syndrome (Tourette's Syndrome) 12/2016
1	Pain (Aches) 11/2015
1	Neuroinflammatory Diseases 11/2015
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2011
1	Abdominal Obesity 07/2011
1	Mental Fatigue 07/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2009
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2009
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2009
1	Tremor (Tremors) 08/2007
1	Glioblastoma (Glioblastoma Multiforme) 03/2007
1	Brain Neoplasms (Brain Tumor) 01/2006
1	AIDS Dementia Complex 04/2005
1	Neoplasm Metastasis (Metastasis) 01/2004
1	Mental Disorders (Mental Disorder) 10/2003

Drug/Important Bio-Agent (IBA)

24	Protons (Proton)IBA 01/2021 - 11/2002
16	Glutamic Acid (Glutamate)FDA Link 12/2021 - 10/2003
10	gamma-Aminobutyric Acid (GABA)IBA 01/2018 - 05/2009
9	N-acetylaspartate (N-acetyl aspartate)IBA 01/2022 - 06/2004
8	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 03/2007
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2008
7	Glutathione (Reduced Glutathione)IBA 01/2019 - 06/2012
7	Aminobutyrates (Aminobutyric Acid)IBA 12/2016 - 02/2012
5	Glutamine (L-Glutamine)FDA Link 01/2017 - 05/2012
4	Riluzole FDA LinkGeneric 12/2021 - 05/2008
3	Ketamine FDA LinkGeneric 01/2020 - 08/2015
3	AntioxidantsIBA 01/2019 - 09/2012
3	Neurotransmitter Agents (Neurotransmitter)IBA 09/2015 - 05/2009
3	Amino Acids FDA Link 08/2015 - 05/2009
3	CreatineIBA 08/2007 - 06/2004
3	Choline (Choline Chloride)IBA 03/2007 - 10/2003
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 11/2012
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2019 - 06/2012
2	Polytetrafluoroethylene (Teflon)FDA Link 01/2019 - 01/2018
2	Phosphorus (Red Phosphorus)IBA 01/2015 - 05/2014
2	Anti-Anxiety Agents (Anxiolytics)IBA 04/2013 - 11/2012
2	LipidsIBA 04/2009 - 06/2008
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	NAD (NADH)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Milnacipran (Ixel)FDA Link 11/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2015
1	Serotonin (5 Hydroxytryptamine)IBA 11/2015
1	Metabotropic Glutamate 5 ReceptorIBA 01/2014
1	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2014
1	Phosphates (Orthophosphate)IBA 09/2012
1	ParvalbuminsIBA 05/2012
1	Corticotropin-Releasing HormoneIBA 07/2011
1	NeuropeptidesIBA 07/2011
1	Insulin (Novolin)FDA Link 07/2011
1	Indicators and Reagents (Reagents)IBA 07/2011
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	Dietary Fats (Dietary Fat)IBA 06/2008
1	NeurotoxinsIBA 08/2007
1	harman (harmane)IBA 08/2007
1	Carmustine (FIVB)FDA Link 03/2007
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 03/2007
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2003
1	AndrogensIBA 10/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 03/2007 - 01/2006
2	Radiotherapy 01/2004 - 10/2003
1	Aftercare (After-Treatment) 11/2015
1	Transcranial Magnetic Stimulation 01/2009
1	Therapeutics 01/2006